This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Celgene Corporation. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Zhiwei Yin: Innovator in Pharmaceutical Formulations
Introduction
Zhiwei Yin is a notable inventor based in Harrison, NJ, who has made significant contributions to the field of pharmaceutical formulations. His work primarily focuses on the development of solid forms and compositions that enhance the efficacy of various compounds.
Latest Patents
Zhiwei Yin holds a patent for a formulation titled "Solid forms comprising (s)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile and salts thereof, and compositions comprising and methods of using the same." This patent outlines innovative formulations, processes, and methods of use related to the salts and solid forms of the compound, showcasing his expertise in the pharmaceutical domain. He has 1 patent to his name.
Career Highlights
Zhiwei Yin is currently employed at Celgene Corporation, a leading biopharmaceutical company known for its focus on innovative therapies. His role at Celgene allows him to work on cutting-edge research and development projects that aim to improve patient outcomes through advanced drug formulations.
Collaborations
Throughout his career, Zhiwei has collaborated with esteemed colleagues, including Gerald D Artman, III and Antonio Christian Ferretti. These collaborations have contributed to the advancement of his research and the successful development of new pharmaceutical products.
Conclusion
Zhiwei Yin's contributions to the field of pharmaceutical formulations highlight his innovative spirit and dedication to improving healthcare solutions. His work continues to impact the industry positively, paving the way for future advancements in drug development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
